555 related articles for article (PubMed ID: 29664678)
1. Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension.
Dai Z; Zhu MM; Peng Y; Jin H; Machireddy N; Qian Z; Zhang X; Zhao YY
Am J Respir Crit Care Med; 2018 Sep; 198(6):788-802. PubMed ID: 29664678
[TBL] [Abstract][Full Text] [Related]
2. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
[TBL] [Abstract][Full Text] [Related]
3. Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension.
Yi D; Liu B; Wang T; Liao Q; Zhu MM; Zhao YY; Dai Z
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804745
[TBL] [Abstract][Full Text] [Related]
4. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
[TBL] [Abstract][Full Text] [Related]
5. Endothelial HIFα/PDGF-B to smooth muscle Beclin1 signaling sustains pathological muscularization in pulmonary hypertension.
Saddouk FZ; Kuzemczak A; Saito J; Greif DM
JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652543
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.
Bourgeois A; Lambert C; Habbout K; Ranchoux B; Paquet-Marceau S; Trinh I; Breuils-Bonnet S; Paradis R; Nadeau V; Paulin R; Provencher S; Bonnet S; Boucherat O
J Mol Med (Berl); 2018 Feb; 96(2):223-235. PubMed ID: 29290032
[TBL] [Abstract][Full Text] [Related]
7. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
Kong D; Liu J; Lu J; Zeng C; Chen H; Duan Z; Yu K; Zheng X; Zou P; Zhou L; Lv Y; Zeng Q; Lu L; Li J; He Y
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):e172-e195. PubMed ID: 38572649
[TBL] [Abstract][Full Text] [Related]
8. HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.
Lin Q; Fan C; Gomez-Arroyo J; Van Raemdonck K; Meuchel LW; Skinner JT; Everett AD; Fang X; Macdonald AA; Yamaji-Kegan K; Johns RA
Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2505-2519. PubMed ID: 31597444
[TBL] [Abstract][Full Text] [Related]
9. CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension.
Pal-Ghosh R; Xue D; Warburton R; Hill N; Polgar P; Wilson JL
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203295
[TBL] [Abstract][Full Text] [Related]
10. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of YTHDF1 prevents hypoxia-induced pulmonary artery smooth muscle cell proliferation by regulating Foxm1 translation in an m6A-dependent manner.
Kang T; Liu L; Tan F; Zhang D; Yu L; Jiang H; Qian W; Hua J; Zheng Z
Exp Cell Res; 2023 Mar; 424(2):113505. PubMed ID: 36736607
[TBL] [Abstract][Full Text] [Related]
13. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
14. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor.
Dai Z; Zhu MM; Peng Y; Machireddy N; Evans CE; Machado R; Zhang X; Zhao YY
Am J Respir Crit Care Med; 2018 Dec; 198(11):1423-1434. PubMed ID: 29924941
[TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha.
Nemenoff RA; Simpson PA; Furgeson SB; Kaplan-Albuquerque N; Crossno J; Garl PJ; Cooper J; Weiser-Evans MC
Circ Res; 2008 May; 102(9):1036-45. PubMed ID: 18340011
[TBL] [Abstract][Full Text] [Related]
17. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
18. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
[TBL] [Abstract][Full Text] [Related]
19. Resident PW1+ Progenitor Cells Participate in Vascular Remodeling During Pulmonary Arterial Hypertension.
Dierick F; Héry T; Hoareau-Coudert B; Mougenot N; Monceau V; Claude C; Crisan M; Besson V; Dorfmüller P; Marodon G; Fadel E; Humbert M; Yaniz-Galende E; Hulot JS; Marazzi G; Sassoon D; Soubrier F; Nadaud S
Circ Res; 2016 Mar; 118(5):822-33. PubMed ID: 26838788
[TBL] [Abstract][Full Text] [Related]
20. Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.
Stenmark KR; Frid MG; Graham BB; Tuder RM
Cardiovasc Res; 2018 Mar; 114(4):551-564. PubMed ID: 29385432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
